Zura Bio (ZURA) Enterprise Value (2021 - 2026)

Zura Bio's Enterprise Value history runs 6 years deep, the most recent figure standing at -$225.6 million for Q1 2026.

• On a quarterly basis, Enterprise Value fell 33.44% year-over-year to -$225.6 million in Q1 2026; TTM through Mar 2026 was -$225.6 million, a 33.44% decrease from a year earlier, with the FY2025 full-year figure at -$109.4 million, up 31.21% from the prior year.
• Enterprise Value slipped to -$225.6 million in Q1 2026 per ZURA's latest filing, from -$109.4 million in the prior quarter.
• Across five years, Enterprise Value topped out at -$1.6 million in Q4 2022 and bottomed at -$225.6 million in Q1 2026.
• The 5-year median for Enterprise Value is -$109.4 million (2025), against an average of -$103.6 million.
• Across the five-year window, Enterprise Value tumbled 5075.88% in 2023 and soared 31.21% in 2025, its largest moves.
• Year by year, Enterprise Value stood at -$1.6 million in 2022, then tumbled by 5075.88% to -$81.1 million in 2023, then slumped by 96.09% to -$159.0 million in 2024, then surged by 31.21% to -$109.4 million in 2025, then slumped by 106.2% to -$225.6 million in 2026.
• Per Business Quant, the three latest ZURA Enterprise Value figures stand at -$225.6 million (Q1 2026), -$109.4 million (Q4 2025), and -$130.3 million (Q3 2025).